What is MiNK Therapeutics, Inc. Common Stock's Market Cap?

MiNK Therapeutics, Inc. Common Stock's Market Cap is $58.4M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Enterprise Value?

MiNK Therapeutics, Inc. Common Stock's Enterprise Value is $49.6M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's EV / EBITDA?

MiNK Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Net Income (TTM)?

MiNK Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.4M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's EBITDA?

MiNK Therapeutics, Inc. Common Stock's EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.23, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Net Debt?

MiNK Therapeutics, Inc. Common Stock's Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.

MiNK Therapeutics, Inc. Common Stock (INKT) Financial Statements

MiNK Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG012J84WM7

XNAS · usd

11.45▼ 0.19 (-1.63%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close11.64

Day's Range11.45 – 11.85

52-Week Range8.46 – 16.98

Volume10.8K

Avg Volume8,127

Share Statistics

Shares Outstanding

Employees15

ExchangeXNAS

Listed2021-10-15

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about MiNK Therapeutics, Inc. Common Stock (INKT)

What is MiNK Therapeutics, Inc. Common Stock's Market Cap?: MiNK Therapeutics, Inc. Common Stock's Market Cap is $58.4M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Enterprise Value?: MiNK Therapeutics, Inc. Common Stock's Enterprise Value is $49.6M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's EV / EBITDA?: MiNK Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Net Income (TTM)?: MiNK Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.4M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's EBITDA?: MiNK Therapeutics, Inc. Common Stock's EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.23, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Net Debt?: MiNK Therapeutics, Inc. Common Stock's Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.